Metraipolis › archive › dc_32f10558ea6e

Treatment outcomes, safety, and characteristics of immune tolerance induction in patients with hemophilia B and inhibitors: a systematic review — Europe PMC PMID:41890554

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41890554
DOI
10.1016/j.rpth.2026.103379
License (as archived)
solo-consultazione
Archived
2026-11-06T07:29:18.041Z
SHA-256 of the archived text
6c1cf9db8ad3b012ea1e924d742c06a0fff9d2e6cd5ff2be9700974e0779e6af
Stable URL of this page
https://metraipolis.com/documento/dc_32f10558ea6e

How to cite

Treatment outcomes, safety, and characteristics of immune tolerance induction in patients with hemophilia B and inhibitors: a systematic review — Europe PMC PMID:41890554 — Europe PMC (en), https://europepmc.org/article/MED/41890554 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_32f10558ea6e (Metraipolis archive dc_32f10558ea6e, sha256 6c1cf9db8ad3b012ea1e924d742c06a0fff9d2e6cd5ff2be9700974e0779e6af)
BibTeX
@misc{dc32f10558ea6e,
  title = {Treatment outcomes, safety, and characteristics of immune tolerance induction in patients with hemophilia B and inhibitors: a systematic review — Europe PMC PMID:41890554},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41890554},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_32f10558ea6e; sha256 6c1cf9db8ad3b012ea1e924d742c06a0fff9d2e6cd5ff2be9700974e0779e6af},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41890554. Agents can read the archived copy with the MCP tool read_document.